Mission control: Drug developers test the 'benefit corporation' business model

Nature Medicine 23, 1117 (2017).
doi:10.1038/nm1017-1117

Author: Arran Frood

Source: Nature Medicine - October 6, 2017 Category: General Medicine Authors: Arran Frood Tags: News Source Type: research